TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
OKYO

OKYO Pharma Ltd

Healthcare · Biotechnology

1.30$ -5.1% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement OKYO
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
– – – – – – – – – – – –
– – – – – +2,624.4% +13,490.6% -98.4% +51,822.2% +11.2% -100.0% +260,942.1%
– – – – – – – – – – – –
– – – – – -83.0% -32.7% +362.2% +293.7% +30.1% -72.7% -19.7%
– -39.8% -65.4% +57.9% – – – +454.3% – – – –
– -37.3% -66.9% +171.4% +360.4% -66.7% +119.6% +87.2% +1.9% +30.1% -12.8% -74.8%
– – – – – – – – – – – –
– -26.4% -58.8% -100.0% – – -2.9% -100.0% – +989.4% -16.1% -46.4%
– – – – – – – – – – – –
– -102.8% – – -20,722,991.6% – – – – – -14,660.0% –
– – – – – – – – – – – –
– -145.4% – – -117.3% – – – – – – –

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?